References
- WHO. Causes of death [Internet]. [cited 2020 Nov 24]. Available from: https://www.who.int/data/maternal-newborn-child-adolescent/monitor.
- Sin DD, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107(11):1514–1519. DOI:https://doi.org/10.1161/01.cir.0000056767.69054.b3
- Brassington K, Selemidis S, Bozinovski S, et al. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease. Clin Sci (Lond). 2019;133(7):885–904. DOI:https://doi.org/10.1042/CS20180316
- Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. DOI:https://doi.org/10.1183/09031936.00128008
- Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018;12:1753465817750524. DOI:https://doi.org/10.1177/1753465817750524
- Theodorakopoulou MP, Schoina M, Sarafidis P. Assessment of endothelial and microvascular function in CKD: older and newer techniques, associated risk factors, and relations with outcomes. Am J Nephrol. 2020;51(12):931–949. doi: https://doi.org/10.1159/000512263.
- Boulanger CM. Secondary endothelial dysfunction: hypertension and heart failure. J Mol Cell Cardiol. 1999;31(1):39–49. DOI:https://doi.org/10.1006/jmcc.1998.0842
- Sarafidis PA, Bakris GL. Review: insulin and endothelin: an interplay contributing to hypertension development? J Clin Endocrinol Metab. 2007;92(2):379–385. DOI:https://doi.org/10.1210/jc.2006-1819
- Wilkes JJ, Hevener A, Olefsky J. Chronic endothelin-1 treatment leads to insulin resistance in vivo. Diabetes. 2003;52(8):1904–1909. DOI:https://doi.org/10.2337/diabetes.52.8.1904
- Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 2014;34(3):509–515. DOI:https://doi.org/10.1161/ATVBAHA.113.300156
- Shechter M, Issachar A, Marai I, et al. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol. 2009;134(1):52–58. DOI:https://doi.org/10.1016/j.ijcard.2008.01.021
- Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104(2):191–196. DOI:https://doi.org/10.1161/01.cir.104.2.191
- Bruzzi P, Predieri B, Patianna VD, et al. Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long-term follow-up study. Pediatr Int. 2014;56(2):188–195. DOI:https://doi.org/10.1111/ped.12220
- Fichtlscherer S, Breuer S, Zeiher AM. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the “vulnerable” patient. Circulation. 2004;110(14):1926–1932. DOI:https://doi.org/10.1161/01.CIR.0000143378.58099.8C
- Polverino F, Celli BR, Owen CA. COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series). Pulm Circ. 2018;8(1):2045894018758528. DOI:https://doi.org/10.1177/2045894018758528
- Ambrosino P, Lupoli R, Iervolino S, et al. Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis. Intern Emerg Med. 2017;12(6):877–885. DOI:https://doi.org/10.1007/s11739-017-1690-0
- Vaes AW, Spruit MA, Theunis J, et al. Endothelial function in patients with chronic obstructive pulmonary disease: a systematic review of studies using flow mediated dilatation. Expert Rev Respir Med. 2017;11:1–1031. DOI:https://doi.org/10.1080/17476348.2017.1389277
- Malerba M, Radaeli A, Nardin M, et al. Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects. Clin Respir J. 2018;12(4):1466–1472. DOI:https://doi.org/10.1111/crj.12686
- Clarenbach CF, Sievi NA, Kohler M. Annual progression of endothelial dysfunction in patients with COPD. Respir Med. 2017;132:15–20. DOI:https://doi.org/10.1016/j.rmed.2017.09.005
- Donaldson GC, Wedzicha JA. COPD exacerbations .1: epidemiology. Thorax. 2006;61(2):164–168. DOI:https://doi.org/10.1136/thx.2005.041806
- Zvezdin B, Milutinov S, Kojicic M, et al. A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation. Chest. 2009;136(2):376–380. DOI:https://doi.org/10.1378/chest.08-2918
- Donaldson GC, Hurst JR, Smith CJ, et al. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137(5):1091–1097. DOI:https://doi.org/10.1378/chest.09-2029
- Campo G, Guastaroba P, Marzocchi A, et al. Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention. Chest. 2013;144(3):750–757. DOI:https://doi.org/10.1378/chest.12-2313
- Polatli M, Cakir A, Cildag O, et al. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation. J Thromb Thrombolysis. 2008;26(2):97–102. DOI:https://doi.org/10.1007/s11239-007-0073-1
- Roland M, Bhowmik A, Sapsford RJ, et al. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax. 2001;56(1):30–35. DOI:https://doi.org/10.1136/thorax.56.1.30
- Herzog R, Álvarez-Pasquin MJ, Díaz C, et al. Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health. 2013;13:154. DOI:https://doi.org/10.1186/1471-2458-13-154
- Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13. DOI:https://doi.org/10.1186/1471-2288-5-13
- Ozben B, Eryüksel E, Tanrikulu AM, et al. Acute exacerbation impairs endothelial function in patients with chronic obstructive pulmonary disease. Turk Kardiyoloji Dernegi arsivi. Turk Kardiyoloji Derneginin Yayin Organidir. 2010;38:1–7.
- Minet C, Vivodtzev I, Tamisier R, et al. Reduced six-minute walking distance, high fat-free-mass index and hypercapnia are associated with endothelial dysfunction in COPD. Respir Physiol Neurobiol. 2012;183(2):128–134. DOI:https://doi.org/10.1016/j.resp.2012.06.017
- Urban MH, Valipour A, Kiss D, et al. Soluble receptor of advanced glycation end-products and endothelial dysfunction in COPD. Respir Med. 2014;108(6):891–897. DOI:https://doi.org/10.1016/j.rmed.2014.03.013
- Scherr A, Schumann DM, Karakioulaki M, et al. Endothelial dysfunction is not a predictor of outcome in chronic obstructive pulmonary disease. Respir Res. 2020;21(1):90. DOI:https://doi.org/10.1186/s12931-020-01345-9
- Marchetti N, Ciccolella DE, Jacobs MR, et al. Hospitalized acute exacerbation of COPD impairs flow and nitroglycerin-mediated peripheral vascular dilation. COPD. 2011;8(2):60–65. DOI:https://doi.org/10.3109/15412555.2011.558541
- Flammer AJ, Anderson T, Celermajer DS, et al. The assessment of endothelial function: from research into clinical practice. Circulation. 2012;126(6):753–767. DOI:https://doi.org/10.1161/CIRCULATIONAHA.112.093245
- Lekakis J, Abraham P, Balbarini A, et al. Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur J Cardiovasc Prev Rehabil. 2011;18(6):775–789. DOI:https://doi.org/10.1177/1741826711398179
- Maruhashi T, Kihara Y, Higashi Y. Assessment of endothelium-independent vasodilation: from methodology to clinical perspectives. J Hypertens. 2018;36(7):1460–1467. DOI:https://doi.org/10.1097/HJH.0000000000001750
- Eickhoff P, Valipour A, Kiss D, et al. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(12):1211–1218. DOI:https://doi.org/10.1164/rccm.200709-1412OC
- Vukic Dugac A, Ruzic A, Samarzija M, et al. Persistent endothelial dysfunction turns the frequent exacerbator COPD from respiratory disorder into a progressive pulmonary and systemic vascular disease. Med Hypotheses. 2015;84(2):155–158. DOI:https://doi.org/10.1016/j.mehy.2014.11.017
- de Matthaeis A, Greco A, Dagostino MP, et al. Effects of hypercapnia on peripheral vascular reactivity in elderly patients with acute exacerbation of chronic obstructive pulmonary disease. Clin Interv Aging. 2014;9:871–878.
- Vaes AW, Spruit MA, Theunis J, et al. Peripheral endothelial function is positively associated with maximal aerobic capacity in patients with chronic obstructive pulmonary disease. Respir Med. 2018;142:41–47. DOI:https://doi.org/10.1016/j.rmed.2018.07.013
- Almagro P, Calbo E, Ochoa de Echagüen A, et al. Mortality after hospitalization for COPD. Chest. 2002;121(5):1441–1448. DOI:https://doi.org/10.1378/chest.121.5.1441
- Soler-Cataluña JJ, Martínez-García MA, Román SP, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. DOI:https://doi.org/10.1136/thx.2005.040527